Healthcare / Medical Device Sales

Oversaw sales responsibilities, education, strategic planning, and customer relationships and led commercialization strategies across six medical equipment management business segments within academic hospitals, IDNs, independent facilities, and surgery centers. Nurtured profitable relationships with corporate supply chain, corporate clinical leadership, corporate VACs, corporate clinical engineering, and CXOs.
• Created programs that drove profits and efficiencies across clinical ops, supply chain, and clinical engineering.
• Engaged with enterprise leadership to drive system-wide initiatives, driving speed to peak value and revenue.
• Achieved $6.94M in total new business bookings.

Generated market expansion and YOY profit growth of both clinical and commoditized Wound Care solutions via solution- based concept sales to hospital marketplace. Called on orthopedic surgery, plastic surgery, gynecology, urology, general surgery, colorectal surgery, vascular surgery, cardiovascular, neurology, oncology, and emergency medicine in ORs, ERs, large hospitals, IDNs, outpatient surgery centers, and private physician practices. Shared mix of economic and clinical messaging with KOLs and key decision makers. Navigated large geographic territory by prioritizing and executing effectively. Converted clients from competitive products via product differentiation, product expertise, and selling skills.
• $600,000 in total growth over two years, 95% to plan (2020), 120% to plan (2019).
• 104% to plan, launched ReliaCatch Specimen Retrieval Device, ID-8 Finalist, Board Co-Lead (2018).
• Field Service Trainer (2018-2021).

Drove sales revenue across innovative Minimally Invasive Surgery (MIS) portfolio focused on obesity and diseases and conditions of gastrointestinal tract, lung, abdominal wall, pelvic region, gynecology, urology, head and neck, and in other areas. Oversaw major accounts and products and received recognition as principal contributor to Medtronic’s divisional sales goals and objects.

Maintained and developed business with existing and new customers while exceeding financial and non-financial targets. Called on OR, surgery centers, hospitals, GPO collaboratives, and VACs. Leveraged existing contracts and new business to deliver incremental revenue. Maximized revenue by driving clinical outcomes of proprietary products to protect business.
• 102% to plan (2017).
• 102% to plan, launched Liquiband Tissue Adhesive (2016).
• 107% to plan; promoted to highest level – Executive Representative (2015).
• 107% to plan (2014).
• Field Service Trainer (2014-2018).
• Leadership Advisory Board member.

Marketed and sold clinical and commoditized suture, tissue adhesive, and hernia repair products including synthetic hernia mesh grafts, Permacol biologic mesh grafts, surgical fixation instrumentation, pre-peritoneal dissection balloon, and abdominal wall fixation / mis devices. Called on general surgeons, trauma surgeons, colorectal surgeons, bariatric surgeons, and plastic surgeons in acute care hospitals, operating rooms, ambulatory surgery centers, and physician offices. Grew Biological Mesh accounts by 88.9% / $187,000 and increased Synthetic Mesh Business 25.7% / $120,000 (2009). Drove Synthetic Mesh sales by 55.7% / $203,000 and increased Hernia Mechanical sales 28.3% / $897,000 (2008).

Converted competitive suture product to Syneture products. Collaborated with surgeons to fine tune suture product selection. Communicated with appropriate hospital stakeholders on activities. Coordinated with nurse educators to provide CME.